Cardiology
Guidelines
Coronary revascularization appropriate use criteria updated
FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYFor ST segment–elevation myocardial infarction (STEMI) patients presenting between 12 and 24...
Conference Coverage
Survey shines new light on weighty comorbidity burden in adult atopic dermatitis
VIENNA – Newly enhanced appreciation of the profound burden of comorbidities associated with adult atopic dermatitis is provided by the Liberty AD...
Conference Coverage
Entresto cuts LV mass in hypertensive patients
NEW ORLEANS – Hypertensive patients without heart failure treated with the heart failure formulation sacubitril plus valsartan had a significantly...
Conference Coverage
Cardiovascular comorbidities common in patients with epilepsy
HOUSTON – Adults with epilepsy reported five of the six most common cardiovascular diseases more often than did adults without epilepsy, according...
From the Journals
Statins protect against Alzheimer’s in most patients
Statins taken to reduce cholesterol also protect most patients against Alzheimer’s disease, but the decrease in risk varies across different...
Conference Coverage
Lupus patients may be shortchanged on lipid management
WASHINGTON
Conference Coverage
Tocilizumab raises cholesterol, but not cardiovascular events
WASHINGTON
Conference Coverage
Diabetes treatment costs doubled in Sweden since 2006
The cost of treating type 2 diabetes in Sweden doubled from 2006 to 2014.
Conference Coverage
Dementia prevalence increased in heart failure patients
NEW ORLEANS - Elderly patients with heart failure had a significantly increased prevalence of both dementia and mild cognitive impairment,...
From the Journals
ASCO and AHA: Maintain high suspicion for cardiac dysfunction
New guideline encourages clinicians to maintain a high suspicion for cardiac dysfunction and a low threshold for cardiac assessment with any...
News from the FDA/CDC
Empagliflozin first antidiabetes drug to gain cardioprotective indication
Empagliflozin is the first antidiabetes medication to be approved for reducing the risk of cardiovascular death in patients with type 2 diabetes...